Literature DB >> 16997171

Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.

Gerrit W Sloof1.   

Abstract

Neoadjuvant or adjuvant multimodality therapy in oesophageal cancer is introduced in an effort to improve prognosis. However, in a substantial fraction of patients there is no response to this non-surgical therapy. Non-invasive imaging modalities such as computed tomography (CT), endoscopic ultrasound (EUS) and 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) have been evaluated for assessing patient response to therapy, and these are described in this review. Currently, FDG-PET seems to be the best available tool for neoadjuvant therapy response assessment in oesophageal cancer.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16997171     DOI： 10.1016/j.bpg.2006.04.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN： 1521-6918            Impact factor:   3.043


  10 in total

1.  The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer.

Authors:  Subhasis Misra; Mark Choi; Alan S Livingstone; Dido Franceschi
Journal:  Surg Endosc       Date:  2011-09-23       Impact factor: 4.584

2.  Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma.

Authors:  Kensuke Yamamura; Daisuke Izumi; Raju Kandimalla; Fuminori Sonohara; Yoshifumi Baba; Naoya Yoshida; Yasuhiro Kodera; Hideo Baba; Ajay Goel
Journal:  Clin Cancer Res       Date:  2019-07-29       Impact factor: 12.531

3.  Impact of PET-CT on primary staging and response control on multimodal treatment of esophageal cancer.

Authors:  Kirsten Thurau; Daniel Palmes; Christiane Franzius; Evgeny Minin; Norbert Senninger; Kai Uwe Juergens; Matthias Bruewer
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

4.  Diagnostic evaluation, surgical technique, and perioperative management after esophagectomy: consensus statement of the German Advanced Surgical Treatment Study Group.

Authors:  Daniel Palmes; Matthias Brüwer; Franz G Bader; Michael Betzler; Heinz Becker; Hans-Peter Bruch; Markus Büchler; Heinz Buhr; Beta Michael Ghadimi; Ulrich T Hopt; Ralf Konopke; Katja Ott; Stefan Post; Jörg-Peter Ritz; Ulrich Ronellenfitsch; Hans-Detlev Saeger; Norbert Senninger
Journal:  Langenbecks Arch Surg       Date:  2011-06-29       Impact factor: 3.445

5.  Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas.

Authors:  Xavier Cuenca; Christophe Hennequin; Elif Hindié; Sofia Rivera; Laetitia Vercellino; Valérie Baruch-Hennequin; Jean-Marc Gornet; Pierre Cattan; Mircea Chirica; Laurent Quéro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-01       Impact factor: 9.236

Review 6.  Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?

Authors:  Theodore D Tsirlis; George Papastratis; Kyriaki Masselou; Christos Tsigris; Antonis Papachristodoulou; Alkiviadis Kostakis; Nikolaos I Nikiteas
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

7.  Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer.

Authors:  Agnieszka Konieczny; Philipp Meyer; Annelies Schnider; Paul Komminoth; Mathias Schmid; Norbert Lombriser; Dominik Weishaupt
Journal:  Eur Radiol       Date:  2013-05-04       Impact factor: 5.315

8.  Radiomics approach for preoperative identification of stages I-II and III-IV of esophageal cancer.

Authors:  Lei Wu; Cong Wang; Xianzheng Tan; Zixuan Cheng; Ke Zhao; Lifen Yan; Yanli Liang; Zaiyi Liu; Changhong Liang
Journal:  Chin J Cancer Res       Date:  2018-08       Impact factor: 5.087

9.  NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial).

Authors:  Mark van Heijl; Jikke M T Omloo; Mark I van Berge Henegouwen; Olivier R C Busch; Hugo W Tilanus; Patrick M M Bossuyt; Otto S Hoekstra; Jaap Stoker; Maarten C C M Hulshof; Ate van der Gaast; Grard A P Nieuwenhuijzen; Han J Bonenkamp; John Th M Plukker; Ernst J Spillenaar Bilgen; Fibo J W Ten Kate; Ronald Boellaard; Jan Pruim; Gerrit W Sloof; J Jan B van Lanschot
Journal:  BMC Med Phys       Date:  2008-07-31

10.  Low-dose spectral insufflation computed tomography protocol preoperatively optimized for T stage esophageal cancer - preliminary research experience.

Authors:  Yue Zhou; Dan Liu; Ping Hou; Kai-Ji Zha; Feng Wang; Kun Zhou; Wei He; Jian-Bo Gao
Journal:  World J Gastroenterol       Date:  2018-09-28       Impact factor: 5.742
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.